These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9666821)
21. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections. Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539 [TBL] [Abstract][Full Text] [Related]
22. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Krampera M; Vinante F; Tavecchia L; Morosato L; Chilosi M; Romagnani S; Zanolin ME; Pizzolo G Clin Exp Immunol; 1999 Aug; 117(2):291-7. PubMed ID: 10444260 [TBL] [Abstract][Full Text] [Related]
23. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis. Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879 [TBL] [Abstract][Full Text] [Related]
24. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis. Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453 [TBL] [Abstract][Full Text] [Related]
25. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals. Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397 [TBL] [Abstract][Full Text] [Related]
26. HIV can induce a TH1 to TH0 shift, and preferentially replicates in CD4+ T-cell clones producing TH2-type cytokines. Romagnani S; Maggi E; Del Prete G Res Immunol; 1994; 145(8-9):611-7; discussion 617-8. PubMed ID: 7754209 [No Abstract] [Full Text] [Related]
27. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. Del Prete G; De Carli M; Almerigogna F; Daniel CK; D'Elios MM; Zancuoghi G; Vinante F; Pizzolo G; Romagnani S FASEB J; 1995 Jan; 9(1):81-6. PubMed ID: 7821763 [TBL] [Abstract][Full Text] [Related]
28. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. Piccinni MP; Giudizi MG; Biagiotti R; Beloni L; Giannarini L; Sampognaro S; Parronchi P; Manetti R; Annunziato F; Livi C J Immunol; 1995 Jul; 155(1):128-33. PubMed ID: 7541410 [TBL] [Abstract][Full Text] [Related]
29. The Th1/Th2 paradigm and experimental murine leishmaniasis. Lohoff M; Gessner A; Bogdan C; Röllinghoff M Int Arch Allergy Immunol; 1998 Mar; 115(3):191-202. PubMed ID: 9531160 [TBL] [Abstract][Full Text] [Related]
31. Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases. Navikas V; Martin C; Matusevicius D; Söderström M; Fredrikson S; Link H Acta Neurol Scand; 1997 Feb; 95(2):99-102. PubMed ID: 9059729 [TBL] [Abstract][Full Text] [Related]
32. CXCR4/CD184 immunoreactivity in T-cell non-Hodgkin lymphomas with an overall Th1- Th2+ immunophenotype. Weng AP; Shahsafaei A; Dorfman DM Am J Clin Pathol; 2003 Mar; 119(3):424-30. PubMed ID: 12645345 [TBL] [Abstract][Full Text] [Related]
33. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [TBL] [Abstract][Full Text] [Related]
34. Role for CD30 in HIV expression. Romagnani S; Annunziato F; Manetti R; Almerigogna F; Biagiotti R; Giudizi MG; Ravina A; Giannò V; Tomasévic L; Maggi E Immunol Lett; 1996 Jun; 51(1-2):83-8. PubMed ID: 8811349 [TBL] [Abstract][Full Text] [Related]
35. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Barker E; Mackewicz CE; Levy JA Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11135-9. PubMed ID: 7479952 [TBL] [Abstract][Full Text] [Related]
36. An alternative view of the Th1/Th2 switch hypothesis in HIV infection. Romagnani S; Maggi E; Del Prete G AIDS Res Hum Retroviruses; 1994 May; 10(5):iii-ix. PubMed ID: 7917511 [TBL] [Abstract][Full Text] [Related]
37. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency. Kutukculer N; Azarsiz E; Aksu G; Karaca NE Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629 [TBL] [Abstract][Full Text] [Related]
38. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations. Mocci S; Coffman RL J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090 [TBL] [Abstract][Full Text] [Related]
39. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA. Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650 [TBL] [Abstract][Full Text] [Related]
40. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy. Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]